Irvin Chairs National IDeA Symposium of Biomedical Research Excellence
- By Jennifer Nachbur
Charles Irvin, Ph.D., University of Vermont professor of medicine and director of the Vermont Lung Center, served as chair of the 4th Biennial National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) National IDeA Symposium of Biomedical Research Excellence (NISBRE), held June 25 to 27, 2012 in Washington, D.C. Irvin has served as chair of the NISBRE executive steering committee since 2005.
A program of the National Center for Research Resources (NCRR) at the NIH, NISBRE showcases the scientific and training accomplishments of the IDeA (Institutional Development Award) program of NCRR. IDeA develops scientific centers of excellence and trains biomedical scientists in the IDeA eligible states (which include Vermont). Currently, the IDeA program consists of two very different programs, the COBRE and INBRE, and – new this year – the creation of a new IDeA program called the IDeA-CTR, Intrastructured for Clinical and Translational Research.
“These groundbreaking NCRR initiatives have led to novel paradigms in the organization of scientific programs and training for productive research careers,” said Irvin in his Program Chair’s Welcome on the NISBRE website.
The central theme for NISBRE 2012 was “Clinical and Translational Research - Opportunities for IDeA”. The UVM College of Medicine is well-represented at the meeting. In addition to Irvin’s leadership and participation, several members of the UVM College of Medicine faculty, as well as graduate students, presented at the meeting. Ralph Budd, M.D., professor of medicine, director of immunobiology and principle investigator of the Immunology and Infectious Diseases COBRE, moderated the Immunology and Infectious Diseases scientific session. Jason Botten, Ph.D., assistant professor of medicine, was an Immunology and Infectious Diseases poster presenter. Douglas Taatjes, Ph.D., professor of pathology and director of the Microscopy Imaging Center, and Beth Kirkpatrick, M.D., associate professor of medicine, presented on “Images for Publication” and “Global Health” respectively during the Scientific Skills workshop. Timothy Hunter, core manager of the Vermont Genetics Network (VGN) Microarray Facility and Vermont Cancer Center DNA Analysis Facility, presented during the Network of IDeA-funded Core Laboratories (NICL) session. Several graduate students from the lab of Yvonne Janssen-Heininger, Ph.D., professor of pathology – James Nolin, Jane Tully, and Sidra Hoffman, M.S. – presented posters during the Lung Biology and Disease session; Nolin received a travel award to attend the symposium. Amanda Kennedy, Pharm.D., B.C.P.S., associate professor of medicine, discussed “Clinical Translational Boot Camp” at the symposium.
UVM has three COBRE grants – a Translational Research in Lung Biology and Disease program established in 2001 and led by Irvin; a Center for Neuroscience Excellence program established in 2000 and led by Rodney Parsons, Ph.D., professor and chair of anatomy and neurobiology; and a Center for Immunology and Infectious Diseases program established in 2006 and led by Budd. In addition, UVM’s VGN is supported by an INBRE grant. Led by Judith Van Houten, Ph.D., professor of biology, and established in 2002, the VGN is a multi-disciplinary scientific research network designed to build and strengthen biomedical research and expertise throughout the state in collaboration with five partner institutions, including Castleton State College, Johnson State College, Middlebury College, Norwich University, and St. Michael’s College.